Indianapolis
Eli Lilly and Company is initiating a $70 million expansion of its global research and development campus in Indianapolis. Providing an additional 130,000 sf of flexible lab space, the project will support collaborative, multidisciplinary research on small molecule pharmaceutical therapies. Completion is expected in 2017.
Source
